Clinical Experience With a Novel Thermosensitive Temporary Coronary Artery Occluder (LeGoo)

In this first large-scale human experience, LeGoo had been an atraumatic, safe, and effective temporary coronary artery occluder. It produced a bloodless field during OPCABG in 91% of target vessels. Improvements on these results with further experience is anticipated.